Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 37:1529-1535
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanada, M.
Right arrow Articles by Ohama, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanada, M.
Right arrow Articles by Ohama, K.

CLINICAL STUDY: RISK FACTORS

Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women

Mitsuhiro Sanada, MD, PhD*, Yukihito Higashi, MD, PhD{dagger}, Keigo Nakagawa, MD{dagger}, Shota Sasaki, MD{dagger}, Ichiro Kodama, MD*, Mikio Tsuda, MD*, Nobutaka Nagai, MD, PhD* and Koso Ohama, MD, PhD*

* Department of Obstetrics and Gynecology, Faculty of Medicine, Hiroshima University, Hiroshima, Japan
{dagger} First Department of Internal Medicine, Faculty of Medicine, Hiroshima University, Hiroshima, Japan

Manuscript received August 14, 2000; revised manuscript received December 28, 2000, accepted January 18, 2001.

Reprint requests and correspondence: Dr. Mitsuhiro Sanada, Department of Obstetrics and Gynecology, Faculty of Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan
msanada64{at}hotmail.com

OBJECTIVES

We sought to evaluate the relationship between the angiotensin-converting enzyme (ACE) genotype and the change in forearm vasoreactivity in response to a three-month course of oral estrogen in postmenopausal women.

BACKGROUND

The ACE genotype is a known predictor of the response to an ACE inhibitor drug; however, it is not clear whether it can modify the effect of estrogen replacement therapy (ERT) on endothelial function in postmenopausal women.

METHODS

Fifty-five postmenopausal women received 0.625 mg of conjugated equine estrogen daily for three months. Forearm blood flow (FBF) was measured by strain-gauge plethysmography.

RESULTS

Twenty-one, 25 and 9 patients had the insertion/deletion (ID), II and DD genotypes, respectively. Plasma ACE activity was significantly higher at baseline in patients with either the DD or ID genotype than in those with the II genotype (p < 0.05). A significant decrease in plasma ACE activity with ERT was seen in the ID and II genotypes (p < 0.05), but not in the DD genotype. There were no significant differences in the FBF responses to reactive hyperemia at baseline between the three groups. Estrogen replacement therapy did not alter the FBF response to reactive hyperemia in the DD genotype (4.0 ± 1.3%), although ERT significantly increased the FBF response in the ID and II genotypes (32.6 ± 7.5% and 30.6 ± 6.5%, respectively; p < 0.05). Forearm blood flow after administration of sublingual nitroglycerin did not change over three months in any of the three groups.

CONCLUSIONS

These findings suggest that the effect of ERT in postmenopausal women on forearm endothelial function may be determined in part by the genotype of the ACE gene.

Abbreviations and Acronyms
  ACE = angiotensin-converting enzyme
  ANOVA = analysis of variance
  eNOS = endothelial nitric oxide synthase
  ERT = estrogen replacement therapy
  FBF = forearm blood flow
  HDL = high density lipoprotein
  ID = insertion/deletion
  LDL = low density lipoprotein
  NO = nitric oxide
  PCR = polymerase chain reaction




This article has been cited by other articles:


Home page
JDRHome page
A. Taguchi, Y. Suei, M. Sanada, Y. Higashi, M. Ohtsuka, T. Nakamoto, M. Tsuda, K. Ohama, and K. Tanimoto
Detection of Vascular Disease Risk in Women by Panoramic Radiography
Journal of Dental Research, October 1, 2003; 82(10): 838 - 843.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Ouchi, M. Ohishi, S. Kihara, T. Funahashi, T. Nakamura, H. Nagaretani, M. Kumada, K. Ohashi, Y. Okamoto, H. Nishizawa, et al.
Association of Hypoadiponectinemia With Impaired Vasoreactivity
Hypertension, September 1, 2003; 42(3): 231 - 234.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Sanada, Y. Higashi, K. Nakagawa, M. Tsuda, I. Kodama, M. Kimura, K. Chayama, and K. Ohama
A Comparison of Low-Dose and Standard-Dose Oral Estrogen on Forearm Endothelial Function in Early Postmenopausal Women
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1303 - 1309.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Sanada, Y. Higashi, K. Nakagawa, M. Tsuda, I. Kodama, M. Kimura, K. Chayama, and K. Ohama
Hormone Replacement Effects on Endothelial Function Measured in the Forearm Resistance Artery in Normocholesterolemic and Hypercholesterolemic Postmenopausal Women
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4634 - 4641.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement